Your browser doesn't support javascript.
loading
Identification of novel quinazolinedione derivatives as RORγt inverse agonist.
Fukase, Yoshiyuki; Sato, Ayumu; Tomata, Yoshihide; Ochida, Atsuko; Kono, Mitsunori; Yonemori, Kazuko; Koga, Keiko; Okui, Toshitake; Yamasaki, Masashi; Fujitani, Yasushi; Nakagawa, Hideyuki; Koyama, Ryoukichi; Nakayama, Masaharu; Skene, Robert; Sang, Bi-Ching; Hoffman, Isaac; Shirai, Junya; Yamamoto, Satoshi.
Afiliação
  • Fukase Y; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Sato A; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: ayumu.sato@takeda.com.
  • Tomata Y; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Ochida A; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Kono M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Yonemori K; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Koga K; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Okui T; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Yamasaki M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Fujitani Y; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Nakagawa H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Koyama R; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Nakayama M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Skene R; Takeda California, Inc., 10410 Science Center Drive, San Diego, CA 92121, United States.
  • Sang BC; Takeda California, Inc., 10410 Science Center Drive, San Diego, CA 92121, United States.
  • Hoffman I; Takeda California, Inc., 10410 Science Center Drive, San Diego, CA 92121, United States.
  • Shirai J; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Yamamoto S; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Bioorg Med Chem ; 26(3): 721-736, 2018 02 01.
Article em En | MEDLINE | ID: mdl-29342416
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinonas / Membro 3 do Grupo F da Subfamília 1 de Receptores Nucleares Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinonas / Membro 3 do Grupo F da Subfamília 1 de Receptores Nucleares Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão